论文部分内容阅读
目的探究酚妥拉明与多巴胺治疗慢性肺心病心衰的疗效。方法随机选取本院2014年3月~2016年7月收治的肺心病心衰患者44例为研究样本,将其分为实验组与对照组,各22例,对照组患者给予常规治疗方法,实验组在次基础上给予酚妥拉明与多巴胺药物治疗,观察对比两组疗效。结果实验组显效20例,有效1例,总有效率为95.5%;对照组显效13例,有效2例,总有效率为68.1%,两组总有效率对比,差异有统计学意义(P<0.05)。结论慢性肺心病心衰应用酚妥拉明与多巴胺有显著疗效,未见不良反应,并发症少,缩短了治疗时间,控制了病情,改善了患者生活质量,值得采用采用与推广。
Objective To investigate the curative effect of phentolamine and dopamine on heart failure of chronic pulmonary heart disease. Methods Forty-four patients with cor pulmonale and heart failure admitted to our hospital from March 2014 to July 2016 were randomly selected as study samples, divided into experimental group and control group, with 22 cases in each group. Patients in control group were given conventional treatment, Group on the basis of phentolamine and dopamine drug treatment, observed and compared two groups of curative effect. Results In the experimental group, 20 cases were markedly effective and 1 case was effective. The total effective rate was 95.5%. In the control group, 13 cases were markedly effective and 2 cases were effective. The total effective rate was 68.1%. There was significant difference between the two groups in total effective rate (P < 0.05). Conclusion Chronic pulmonary heart failure with phentolamine and dopamine has a significant effect, no adverse reactions, fewer complications, shorten the treatment time, control the disease, improve the quality of life of patients, it is worth to adopt and promote.